[Pubmed] Myasthenia gravis due to anti-PD-1 treatment for an advanced colon cancer patient: a case report and literature

[RSS-Bot]

J Neurol. 2024 Jun 12. doi: 10.1007/s00415-024-12494-y. Online ahead of print.

ABSTRACT

With the advancement of cancer treatment technologies, immunotherapy has begun to be widely utilized. Colon cancer is one of the most common types of cancer, with metastasis being a frequent occurrence in late-stage patients. Hence, immunotherapy, as an emerging and potentially effective treatment modality, merits exploration to enhance patient survival rates and clinical benefits. However, various immune-related adverse events cannot be entirely avoided. Myasthenia gravis induced by immunotherapy serves as a rare but potentially lethal adverse event, and it has been increasingly reported. Understanding the mechanisms of irAEs can aid in controlling the side effects induced by treatment. Here, we reported a case of myasthenia gravis occurring after anti-PD-1 therapy for late-stage colon cancer.

PMID:38864881 | DOI:10.1007/s00415-024-12494-y


Source: https://pubmed.ncbi.nlm.nih.gov/3886488 ... t9+e462414